🎙️ We’re back with the third episode of Parkinson Weekly, hosted by Prof. Bas Bloem.
This week’s Article of the Week explores an exciting area of research:
“Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s disease in the UK: a phase 2, multi-centre, double-blind, parallel-group, randomised, placebo-controlled trial.”
👉 You can read the full article here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02808-3/fulltext & https://pubmed.ncbi.nlm.nih.gov/39919773/
Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.
View all episodes
By Oruen CNS🎙️ We’re back with the third episode of Parkinson Weekly, hosted by Prof. Bas Bloem.
This week’s Article of the Week explores an exciting area of research:
“Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s disease in the UK: a phase 2, multi-centre, double-blind, parallel-group, randomised, placebo-controlled trial.”
👉 You can read the full article here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02808-3/fulltext & https://pubmed.ncbi.nlm.nih.gov/39919773/
Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.